Rajamanickam C, Sakthivel S, Babu G J, Lottspeich F, Kadenbach B
Department of Biochemistry, School of Biological Sciences, Centre for Advanced Studies in Functional Genomics, Madurai Kamaraj University, India.
Basic Res Cardiol. 2001 Feb;96(1):23-33. doi: 10.1007/s003950170074.
Earlier studies from this laboratory have identified a novel high molecular weight (182 kDa) serum protein suggested to be involved in the development of cardiac hypertrophy. In the present case the role of this novel serum protein in the development of pressure-induced cardiac hypertrophy and the molecular events associated with it in experimental rats has been investigated. Multiple injections of this purified protein intravenously (through tail vein) into the normal animals lead to the development of cardiac hypertrophy and this is accompanied by an induction of muscle specific genes such as that of MLC2 and beta-MHC characteristic of pressure overloaded heart. Further, the hypertrophy-specific serum protein has been found to be identical to rat alpha-2 macroglobulin (alpha-2M) in molecular weight (182 kDa) and in its appearance in blood serum. alpha-2M is an acute phase serum protein that increases markedly after inflammatory stimuli in hepatocytes in liver and gets secreted into the blood. The studies at present suggest that the 182kDa serum protein that appeared during the early stage of development of cardiac hypertrophy in aorta constricted rats is a glycoprotein localized in the heart that showed immunological cross reactivity with alpha-2M and is expressed in the heart as evinced by Northern blot analysis. Further this protein showed certain differences from rat alpha-2M under denaturing conditions in isoelectric focusing and partial peptide mapping. Partial peptide sequencing of the internal peptides of tryptic digest of 182 kDa showed 100% identity of the sequences with alpha-2M sequences. Rat alpha-2M does not, however, have any influence on the development of cardiac hypertrophy and its antibody does not cross react with the 182 kDa protein. These data suggest that the 182 kDa protein that may play an indispensable role in the development of cardiac hypertrophy in experimental rats is cardiac specific, and may be an isoform of liver alpha-2M belonging to macroglobulin family.
该实验室早期的研究鉴定出一种新型高分子量(182 kDa)血清蛋白,提示其参与心脏肥大的发生发展。在本研究中,已对这种新型血清蛋白在实验大鼠压力诱导性心脏肥大发生发展中的作用及其相关分子事件进行了研究。将这种纯化蛋白多次静脉内(通过尾静脉)注射到正常动物体内会导致心脏肥大的发生,同时伴随着肌肉特异性基因如MLC2和β - MHC的诱导,这些基因是压力超负荷心脏的特征性基因。此外,已发现肥大特异性血清蛋白在分子量(182 kDa)及其在血清中的表现上与大鼠α - 2巨球蛋白(α - 2M)相同。α - 2M是一种急性期血清蛋白,在肝脏中肝细胞受到炎症刺激后会显著增加,并分泌到血液中。目前的研究表明,在主动脉缩窄大鼠心脏肥大发育早期出现的182 kDa血清蛋白是一种定位于心脏的糖蛋白,与α - 2M表现出免疫交叉反应,并且通过Northern印迹分析表明其在心脏中表达。此外,这种蛋白在变性条件下的等电聚焦和部分肽图谱分析中与大鼠α - 2M存在某些差异。对182 kDa胰蛋白酶消化产物内部肽段的部分肽测序显示,其序列与α - 2M序列100%相同。然而,大鼠α - 2M对心脏肥大的发生发展没有任何影响,其抗体也不与182 kDa蛋白发生交叉反应。这些数据表明,在实验大鼠心脏肥大发生发展中可能起不可或缺作用的182 kDa蛋白是心脏特异性的,可能是属于巨球蛋白家族的肝脏α - 2M的一种同工型。